JP2002534393A5 - - Google Patents

Download PDF

Info

Publication number
JP2002534393A5
JP2002534393A5 JP2000592015A JP2000592015A JP2002534393A5 JP 2002534393 A5 JP2002534393 A5 JP 2002534393A5 JP 2000592015 A JP2000592015 A JP 2000592015A JP 2000592015 A JP2000592015 A JP 2000592015A JP 2002534393 A5 JP2002534393 A5 JP 2002534393A5
Authority
JP
Japan
Prior art keywords
growth hormone
transplantation
induces
initiated
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000592015A
Other languages
English (en)
Japanese (ja)
Other versions
JP4808316B2 (ja
JP2002534393A (ja
Filing date
Publication date
Priority claimed from EP98124834A external-priority patent/EP1016413A1/en
Application filed filed Critical
Publication of JP2002534393A publication Critical patent/JP2002534393A/ja
Publication of JP2002534393A5 publication Critical patent/JP2002534393A5/ja
Application granted granted Critical
Publication of JP4808316B2 publication Critical patent/JP4808316B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000592015A 1998-12-30 1999-12-30 多能性造血幹細胞の動員を刺激するためのヒト成長ホルモン Expired - Fee Related JP4808316B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (en) 1998-12-30 1998-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
EP98124834.7 1998-12-30
PCT/EP1999/010470 WO2000040260A1 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (3)

Publication Number Publication Date
JP2002534393A JP2002534393A (ja) 2002-10-15
JP2002534393A5 true JP2002534393A5 (cg-RX-API-DMAC7.html) 2010-11-18
JP4808316B2 JP4808316B2 (ja) 2011-11-02

Family

ID=8233268

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000592015A Expired - Fee Related JP4808316B2 (ja) 1998-12-30 1999-12-30 多能性造血幹細胞の動員を刺激するためのヒト成長ホルモン

Country Status (15)

Country Link
US (1) US20060029581A1 (cg-RX-API-DMAC7.html)
EP (3) EP1016413A1 (cg-RX-API-DMAC7.html)
JP (1) JP4808316B2 (cg-RX-API-DMAC7.html)
AT (1) ATE342064T1 (cg-RX-API-DMAC7.html)
AU (2) AU772222B2 (cg-RX-API-DMAC7.html)
BR (1) BR9916726A (cg-RX-API-DMAC7.html)
CA (1) CA2354194A1 (cg-RX-API-DMAC7.html)
CY (1) CY1107603T1 (cg-RX-API-DMAC7.html)
DE (1) DE69933581T2 (cg-RX-API-DMAC7.html)
DK (1) DK1140149T3 (cg-RX-API-DMAC7.html)
ES (1) ES2275359T3 (cg-RX-API-DMAC7.html)
IL (2) IL143994A0 (cg-RX-API-DMAC7.html)
PT (1) PT1140149E (cg-RX-API-DMAC7.html)
SI (1) SI1140149T1 (cg-RX-API-DMAC7.html)
WO (1) WO2000040260A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60140051D1 (de) * 2000-06-07 2009-11-12 Merck Serono Sa Coinsins Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
JP2004504834A (ja) 2000-08-01 2004-02-19 イスム リサーチ ディベロップメント カンパニー 胚性細胞の定方向分化
CN102302493B (zh) 2001-07-31 2015-08-12 健赞股份有限公司 活化祖细胞/干细胞的方法
WO2005032572A2 (en) 2003-10-03 2005-04-14 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
BRPI0519170A8 (pt) * 2004-12-22 2018-05-08 Ambrx Inc formulações de hormônio de crescimento humano que compreendem um aminoácido não naturalmente codificado
JP2013515081A (ja) * 2009-12-21 2013-05-02 アンブルックス,インコーポレイテッド 修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
EP0563485A1 (en) * 1992-03-30 1993-10-06 Schering-Plough In vitro generation of human dendritic cells and uses thereof
JPH08511263A (ja) * 1993-06-15 1996-11-26 ブリテッシュ バイオテック ファーマシューティカルズ リミテッド 造血細胞の放出と可動化
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
DE69433967D1 (de) * 1993-10-06 2004-09-30 Univ Florida Stammzellen-proliferations-faktor
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
CA2227241C (en) * 1995-07-21 2004-12-21 THE GOVERNMENT OF THE UNITED STATES, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
WO1997026326A1 (en) * 1996-01-16 1997-07-24 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
JP4042925B2 (ja) * 1996-11-20 2008-02-06 シスメックス株式会社 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
EP1016414B1 (en) * 1998-12-17 2004-09-08 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
DE60140051D1 (de) * 2000-06-07 2009-11-12 Merck Serono Sa Coinsins Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Similar Documents

Publication Publication Date Title
US20170157291A1 (en) Tissue transplant compositions and methods for use
JP2002506831A5 (cg-RX-API-DMAC7.html)
CA2387542A1 (en) Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation
ATE153856T1 (de) Zusammensetzung zur stimulierung des immunsystems
YU18899A (sh) L-nukleozidi purina, njihovi analogoni i primena
JP2018537472A (ja) 増殖造血幹細胞/前駆細胞集団の利用
CA2208047A1 (en) Increasing creatine and glycogen concentration in muscle
JP2002524421A5 (cg-RX-API-DMAC7.html)
IL153288A0 (en) Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis
DE60313356D1 (de) Verwendungvon dextransulfat zur behandlung von ibmir
WO2002017935A3 (en) A method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease
JP2008531696A5 (cg-RX-API-DMAC7.html)
Okuda et al. Treatment of chronic desquamative gingivitis using tissue-engineered human cultured gingival epithelial sheets: a case report.
JP2008536930A5 (cg-RX-API-DMAC7.html)
JP2003513034A5 (cg-RX-API-DMAC7.html)
JP2000178203A5 (cg-RX-API-DMAC7.html)
JP2005506959A5 (cg-RX-API-DMAC7.html)
WO2008045528A3 (en) Methods and compositions for the treatment of cancer
EP1016414A3 (en) Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
Borgies et al. Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation
Villaron et al. Bone marrow mesenchymal stem cells chimerism after allogeneic hematopoietic transplantation
Wang et al. Omentum transplantation and revascularization
NO20022109D0 (no) Anvendelse av treosulfan for behandling av pasienter för benmargs- eller blodstamcelletansplantasjon
Kalvit De novo histoid leprosy in an immunocompetent male: a rare case report from North east India
Mori et al. Dramatic Combination therapy with Ribavirin and Polyoxometalate in the treatment of Influenza A virus infected mice.